Even people with 20/20 eyesight should be familiar with this scenario: You're enjoying a clear view when a faint doodle shape drifts into your peripheral vision like an organism under a microscope. Floaters affect almost everyone, but there's currently no medically accepted, non-invasive way to treat them. Two doctors with Ophthalmic Consultants of Boston are working to change that. As IFLScience reports, the team believes that lasers may be the solution to bothersome eye squiggles.
As Chirag Shah and Jeffrey Heier write in their study in the journal JAMA Ophthalmology, lasers can be used to safely combat the underlying causes of floaters. Also known as muscae volitantes, Latin for “hovering flies,” the condition comes from physical debris leaking into your eyeball. The front of your eyes is filled with a liquid called vitreous humor, and when drops of that gelatinous substance break off from the whole, the bits cast shadows on your retinas that look like gray blobs. Because floaters literally float inside your eyes, trying to focus on one is almost impossible.
These spots aren't typically a problem for young people, but as you get older your vitreous humor becomes more watery, which increases the chance of it slipping out and clouding your vision. Retinal detachment and retinal tears are also rare but serious causes of symptomatic floaters.
Shah and Heier tested a new method of pinpointing and eliminating floaters with a YAG laser (a type of laser often used in cataract surgery) on 36 patients. An additional 16 test subjects were treated with a sham laser as a placebo. They found that 54 percent of the treated participants saw their floaters decrease over six months, compared to just 9 percent of the control group. So far, the procedure appears be safe and free of side effects, but researchers noted that more follow-up time is needed to determine if those results are long-term.
At the moment, people with symptomatic floaters can choose between surgery or living with the ailment for the rest of their lives. YAG laser treatment may one day offer a safe and easy alternative, but the researchers say they will need to expand the size of future studies before the treatment is ready to go public.